Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells
- PMID: 20107863
- DOI: 10.1007/s10637-010-9387-5
Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells
Abstract
Peloruside A, isolated from the marine sponge Mycale hentscheli, has a similar mechanism of action to paclitaxel (Taxol®), a drug used clinically to treat tumors of the breast, ovary and lung. Paclitaxel and peloruside stabilize the polymerized form of tubulin and arrest cells in G₂/M of the cell cycle. We have therefore used two-dimensional electrophoresis of proteins to examine the effect of peloruside A on the human HL-60 promyeloid leukemic cell line. Our goals included investigation whether affected proteins could be mapped onto pathways that predicted the cellular effects of this compound. In response to 100 nM peloruside A treatment for 24 h, seventeen identified proteins showed significant change in abundance with fourteen increases and three decreases. Use of Ingenuity Pathways Analysis confirmed that peloruside A affected pathways consistent with the known effects on microtubules and apoptosis. Our results also indicate a potential role of c-Myc in the cellular actions of peloruside consistent with an induction of aneuploidy seen at low concentrations of peloruside.
Similar articles
-
Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A.Invest New Drugs. 2012 Feb;30(1):121-9. doi: 10.1007/s10637-010-9540-1. Epub 2010 Sep 23. Invest New Drugs. 2012. PMID: 20862516
-
Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.Mar Drugs. 2010 Mar 31;8(4):1059-79. doi: 10.3390/md8041059. Mar Drugs. 2010. PMID: 20479967 Free PMC article. Review.
-
Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.Cancer Res. 2002 Jun 15;62(12):3356-60. Cancer Res. 2002. PMID: 12067973
-
Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines.Mol Pharm. 2007 Mar-Apr;4(2):269-80. doi: 10.1021/mp060101p. Mol Pharm. 2007. PMID: 17397239
-
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.Nat Prod Rep. 2016 Apr;33(4):549-61. doi: 10.1039/c5np00146c. Epub 2016 Feb 12. Nat Prod Rep. 2016. PMID: 26867978 Review.
Cited by
-
Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A.Invest New Drugs. 2012 Feb;30(1):121-9. doi: 10.1007/s10637-010-9540-1. Epub 2010 Sep 23. Invest New Drugs. 2012. PMID: 20862516
-
Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside A.Invest New Drugs. 2015 Jun;33(3):564-74. doi: 10.1007/s10637-015-0232-8. Epub 2015 Mar 31. Invest New Drugs. 2015. PMID: 25822110
-
Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.Mar Drugs. 2010 Mar 31;8(4):1059-79. doi: 10.3390/md8041059. Mar Drugs. 2010. PMID: 20479967 Free PMC article. Review.
-
Peloruside A, a microtubule-stabilizing agent, induces aneuploidy in ovarian cancer cells.Invest New Drugs. 2016 Aug;34(4):424-38. doi: 10.1007/s10637-016-0355-6. Epub 2016 May 7. Invest New Drugs. 2016. PMID: 27155614
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources